Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
Authors:
Open Access
- 1 August 2021
- journal article
- review article
- Published by Taylor & Francis in Journal of Hepatocellular Carcinoma
- Vol. ume 8, 985-996
Abstract
Ferroptosis is a special form of regulatory cell death caused by the accumulation of intracellular iron and lipid peroxidation. Here, we summarize the research progress on ferroptosis in hepatocellular carcinoma (HCC), trace the development of the concept of ferroptosis and its key regulatory factors, and discuss the application value of ferroptosis in the treatment of HCC from different perspectives. We believe that exploring the relationship between ferroptosis and HCC and clarifying the metabolism and expression of ferroptosis-specific genes and molecules will accelerate the development of novel ferroptosis-related molecules as HCC markers and therapeutic targets. We hope to provide a theoretical basis for better diagnosis and treatment to effectively improve the prognosis of patients with HCC.Keywords
This publication has 120 references indexed in Scilit:
- Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective AutophagyMolecular Cell, 2013
- A novel synergistic effect of iron depletion on antiangiogenic cancer therapyInternational Journal of Cancer, 2012
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- The FBXL5-IRP2 Axis Is Integral to Control of Iron Metabolism In VivoCell Metabolism, 2011
- Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-Carcinogenesis, 2011
- Detergent-Resistant Microdomains Determine the Localization of σ-1 Receptors to the Endoplasmic Reticulum-Mitochondria JunctionMolecular Pharmacology, 2010
- Iron-Dependent Regulation of MDM2 Influences p53 Activity and Hepatic CarcinogenesisThe American Journal of Pathology, 2010
- Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking β-catenin and cyclooxygenase-2Molecular Cancer Therapeutics, 2009
- Regulation of HSP27 on NF-κB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosisBMC Cancer, 2009
- Disorders of Iron MetabolismNew England Journal of Medicine, 1999